HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ultrasound for kidney access in percutaneous nephrolithotomy: a contemporary review.

Abstract
Nowadays percutaneous nephrolithotomy (PCNL) is the standard of care for renal staghorn calculus or large (>20 mm) pelvic or caliceal stones, as well as for the failure of other treatment options. This review aims to evaluate the contemporary use of ultrasound imaging in PCNL, by comparing it to conventional fluoroscopy, reviewing data regarding the complication and success rate of nephrostomy tract creation and stone free rate (SFR), as well as data concerning the learning curve for these procedures and cost indicators. The evidence acquired shows that the ultrasound guided access (USGA) is a comparable method with the classic fluoroscopic guided access (FGA), with a similar safety profile, with a significant reduction in radiation exposure, up to radiation free complete PCNL. USGA PCNL seems to lead to decreased bleeding and need for transfusion, especially when the Doppler mode is used, and also to a slightly higher SFR than conventional FGA PCNL. USGA PCNL reduces the overall costs of the procedure by about 30% and can be safely learnt and performed by urologists. For an experienced endourologist, familiar withFGA PCNL, the learning curve for shifting to USGA PCNL is of approximately 20 procedures.
AuthorsAlexandru Iordache, Catalin Baston, Silviu-Stelian Guler-Margaritis, Emil Angelescu, Vasile Cerempei, Traxer Olivier, Ioanel Sinescu
JournalMedical ultrasonography (Med Ultrason) Vol. 20 Issue 4 Pg. 508-514 (12 08 2018) ISSN: 2066-8643 [Electronic] Romania
PMID30534660 (Publication Type: Journal Article, Review)
Topics
  • Humans
  • Kidney (diagnostic imaging, surgery)
  • Kidney Calculi (diagnostic imaging, surgery)
  • Nephrolithotomy, Percutaneous (methods)
  • Ultrasonography, Interventional (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: